Tumours in the stomach are also called stomach tumours or abdominal tumours. When the accumulation of abnormal cells present in the stomach leads to abnormal growth of tissue, a tumour is formed ...
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...
Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and Australia evaluating ATN-022 ...